- Home
- AZTR vs TTNP Comparison
AZTR vs TTNP Comparison
Compare AZTR & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTR
- TTNP
- Stock Information
- Founded
- AZTR 2014
- TTNP 1991
- Country
- AZTR United States
- TTNP United States
- Employees
- AZTR N/A
- TTNP N/A
- Industry
- AZTR Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AZTR Health Care
- TTNP Health Care
- Exchange
- AZTR Nasdaq
- TTNP Nasdaq
- Market Cap
- AZTR 3.2M
- TTNP 3.0M
- IPO Year
- AZTR 2023
- TTNP 1996
- Fundamental
- Price
- AZTR $0.25
- TTNP $3.79
- Analyst Decision
- AZTR
- TTNP
- Analyst Count
- AZTR 0
- TTNP 0
- Target Price
- AZTR N/A
- TTNP N/A
- AVG Volume (30 Days)
- AZTR 3.0M
- TTNP 41.9K
- Earning Date
- AZTR 03-14-2025
- TTNP 01-03-2025
- Dividend Yield
- AZTR N/A
- TTNP N/A
- EPS Growth
- AZTR N/A
- TTNP N/A
- EPS
- AZTR N/A
- TTNP N/A
- Revenue
- AZTR $97,500.00
- TTNP N/A
- Revenue This Year
- AZTR N/A
- TTNP N/A
- Revenue Next Year
- AZTR N/A
- TTNP N/A
- P/E Ratio
- AZTR N/A
- TTNP N/A
- Revenue Growth
- AZTR N/A
- TTNP N/A
- 52 Week Low
- AZTR $0.24
- TTNP $3.03
- 52 Week High
- AZTR $68.40
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- AZTR 36.62
- TTNP 48.54
- Support Level
- AZTR $0.24
- TTNP $3.14
- Resistance Level
- AZTR $0.65
- TTNP $3.38
- Average True Range (ATR)
- AZTR 0.06
- TTNP 0.22
- MACD
- AZTR -0.02
- TTNP 0.02
- Stochastic Oscillator
- AZTR 1.71
- TTNP 52.24
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.